Anika Closes Divestiture Of Its Arthrosurface Business And Intention To Divest Of Parcus Medical Business
Anika Therapeutics, Inc. +0.17%
Anika Therapeutics, Inc. ANIK | 17.26 | +0.17% |
The sale of the Company's Arthrosurface business to Phoenix Brio, Incorporated closed today, October 31, 2024. The Company received consideration of $10 million in the form of a ten year non-interest bearing promissory note for $7 million, and an estimated $3 million of additional consideration subject to the sales performance of Arthrosurface.